Oncotelic Therapeutics, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Oncotelic Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $847.47K.
- Oncotelic Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-09-30 was $316.13K.
- Oncotelic Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-03-31 was $70.20K, a 37.89% decline year-over-year.
- Oncotelic Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $532.40K, a 63.23% increase year-over-year.
- Oncotelic Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $479.59K, a 25.70% decline from fiscal 2024.
- Oncotelic Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $645.43K, a 27.83% increase from fiscal 2023.
- Oncotelic Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $504.93K, a 19.18% decline from fiscal 2022.
- Oncotelic Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $624.75K, a 197.07% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $847.47K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $479.59K 10-K · filed 2026-04-15 | |
| 2025-09-30 | $316.13K 10-Q · filed 2025-11-17 | |
| 2025-03-31 | $70.20K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $645.43K 10-K · filed 2026-04-15 | |
| 2024-06-30 | $532.40K 10-Q · filed 2025-11-17 | |
| 2024-03-31 | $113.03K 10-Q · filed 2025-11-17 | |
| 2023-12-31 | $504.93K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $35.27K 10-Q · filed 2024-11-19 | |
| 2023-06-30 | $326.16K 10-Q · filed 2024-11-19 | |
| 2023-03-31 | $71.75K 10-Q · filed 2024-11-19 | |
| 2022-12-31 | $624.75K 10-K · filed 2024-04-12 | |
| 2022-09-30 | $241.75K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $331.25K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $210.30K 10-K/A · filed 2023-04-20 | |
| 2021-03-31 | $210.30K 10-Q · filed 2022-11-18 | |
| 2019-12-31 | $906.36K 10-K · filed 2021-04-15 | |
| 2019-03-31 | $238.09K 10-Q · filed 2020-11-16 |